Modulation of TNF-α activity in tumor PC cells using anti-CD45 and anti-CD95 monoclonal antibodies

Cancer Letters

Volumn 214, Issue 1, 2004, Pages 55-61

  Jurišić, Vladimir ^c   Bogdanovic, Gordana ^a   Srdic, Tatjana ^a   Jakimov, Dimitar ^a   Mrdjanovic, Jasna ^a   Baltic, Mirjana ^a   Baltic, Vladimir V ^a,b  

^a Novi Sad   (Macedonia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Anti CD45; Anti CD95 antibody; Antigen expression; Apoptosis; Cell culture; Flow cytometry; Necrosis; TNF ; Tumor cells

Indexed keywords

CD45 ANTIBODY; CD95 ANTIBODY; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERMETHOD COMPARISON; MALE; NATURAL KILLER CELL; NECROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

EID: 4344622416     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.05.011     Document Type: Article

References (30)

1. K. Haranaka, and N. Satomi Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro Jpn. J. Exp. Med. 51 1991 191 194
2. C. Zheng, G. Fischer, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo Induction of apoptosis in mature T cells by tumor necrosis factor Nature 377 1995 348 352
3. J. Macia, X. Gomez, A. Esquerda, B. Perez, V. Callao, and C. Marzo Values of the determination of TNF-α in the plasma of patients with non-Hodgkin's lymphoma Leuk. Lymph. 20 20 1996 481 486
4. G. Salles, J. Bienvenu, Y. Bastion, Y. Barbier, C. Doche, and K. Warzocha Elevated circulating levels of TNF-α and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients Br. J. Haematol. 93 1996 352 359
5. V. Jurisic, I. Spuzic, and G. Konjevic A comparison of NK cell activity with effects of TNF-alpha against K-562 cells, determined by LDH release assay Cancer Lett. 138 1999 67 72
6. V. Jurisic, V. Bumbasirevic, G. Konjevic, B. Djuricic, and I. Spuzic TNF-alpha induced changes in LDH isotype profile following triggering of apoptosis in PBMC of non-Hodgkin's lymphoma Ann. Haematol. 83 2004 82 91
7. K. Warzocha, G. Salles, J. Bienvenu, Y. Bastion, C. Dumontet, and N. Renard The tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients J. Clin. Oncol. 15 1997 499 508
8. M. Grell, G. Zimmermann, D. Hulser, K. Pfizenmaier, and A. Scheurich TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways J. Immunol. 153 1994 1963 1972
9. C.A. Smith, T. Farrah, and G. Goodwin The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death Cell 76 1994 959 962
10. H.J. Gruss, and S.K. Dower TNF ligand superfamily: involvement in the pathology of malignant lymphomas Blood 85 1995 3378 3386
11. S.Y. Lee, S.Y. Lee, G. Lee, M.L. Kandala, H.C. Liou, and Y. Choi CD30/TNF receptor-associated factor interaction: NF-Kappa B activation and binding specificity Proc. Natl Acad. Sci. 18 1996 9699 9703
12. M. Suzuki, H. Matsuoka, K. Yamashita, K. Maeda, K. Kawano, H. Uno, and H.M. Tsubouchi CD 45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia Leuk. Lymph. 28 1998 583 590
13. M.X. Wu, Z. Ao, M. Hegen, C. Morimoto, and F. Schlossman Requirement of Fas (CD95), CD45, and CD 11/CD 18 in monocyte-dependent apoptosis of human T cells J. Immunol. 157 1996 707 713
14. M.F. Peter, and P.H. Krammer The CD95(Apo-1/Fas) DISC and beyond Cell Death Differ. 10 2003 26 35
15. A.E. Medvedev, A.C. Jonhsen, J. Haux, B. Steinkjer, K. Egeberg, and D.H. Lynch Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity Cytokine 9 1997 394 404
16. A.H. Wyllie Apoptosis: cell death in tissue regulation J. Pathol. 153 1995 313 316
17. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 456 1462
18. L. Sachs, and J. Lotem Control of programmed cell death in normal and leukemic cells: new implication for therapy Blood 82 1993 21 25
19. H. Vajant, and P. Scheurich Tumor necrosis factor receptor-associated factor (TRAF2) and its role in TNF signaling Int. J. Biochem. Cell Biol. 33 2001 19 32
20. H.J. Gruss Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily Int. J. Clin. Lab. Res. 26 1996 143 159
21. K. Sasaki, T. Kobayashi, S. Imammura, T. Shigekura, R. Kato, and Y. Kawamoto Flow cytometry analysis of the Fas ligand expression of activated lymph node T-cells Immunol. Lett. 55 1997 11 13
22. J.M. Penninger, J.I. Sasaki, T. Sasaki, and A.J. Olivera-dos-Santos CD45: new jobs for an old acquaintance Nat. Immunol. 2 2001 389 396
23. H. Wajant, M. Grell, and P. Scheurich TNF receptor associated factors in cytokine signaling Cytokine Growth Factor Rev. 10 1999 15 26
24. M. Higuchi, and B. Aggarwal Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation and differentiation J. Immunol. 1994 4017 4025
25. H.W.G. Wong, and D. Goeddel Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways J. Immunol. 152 1994 1751 1755
26. K. Chlichlia, M.E. Peter, M. Rocha, C. Scaffidi, M. Bucur, and P.H. Krammer Caspase activation is required for nitric oxide-mediated CD95 (Apo-1/FAs) dependent and independent apoptosis in human neoplastic lymphoid cells Blood 91 1998 4311 4320
27. M.J. Lorenzo-Martinez, A. Alava, A. Anel, A. Pineiro, and J. Naval Release of performed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells Immunology 89 1996 511 517
28. J. Reed Dysregulation of apoptosis in cancer J. Clin. Oncol. 17 1999 2941 2953
29. S. Fulda, G. Straus, E. Meyer, and K.M. Debatin Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells Blood 95 2000 301 307
30. C. Fiesen, S. Fulda, and K.M. Debatin Cytotoxic drugs and CD95 pathway Leukemia 13 1999 1854 1858